WILIMINGTON – Global biopharmaceutical company Incyte announced April 2 that it was studying whether it could repurpose its blockbuster drug Jakafi to aid in the treatment of COVID-19 patients. The company headquartered off U.S. Route ...
In 1991, CB Research and Development was founded in a 2,000-square-foot facility to synthesize specialized chemical compounds for drug-makers. There were three employees. That same year, Incyte was founded in Palo Alto, California, to focus ...
Incyte Corporation has announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi® (ruxolitinib) for the treatment of steroid-refractory acute GVHD in adult and pediatric patients 12 years and older. Jakafi is the ...
Reid Huber, executive vice president and chief scientific officer at Incyte, has a simple formula for how the company can keep ahead in a drug therapy environment that is moving more rapidly every year. “Speed, ...
Incyte Corporation today reported a $12 million net loss for the fourth quarter, compared to net income of $34 million for the same period in 2016. That’s a per-share loss of 6 cents for the ...
Incyte Corporation, one of the region’s largest pharmaceutical companies, today reported fourth-quarter and year-end financial gains for 2016. The company attributes the success, in part, to the growth of a few key products and the ...
WILMINGTON — Incyte Corporation, based in Wilmington, has announced the first patient has been treated in the REACH-1 pivotal Phase 2 trial evaluating its ruxolitinib drug, trademarked Jakafi. The drug was used in combination with ...
Brand New: The Power of Rebranding - Brand New: The Power of RebrandingYou’ve heard about it. You’ve seen the results. Maybe you’ve even been part of a rebranding effort. But do you
Does Your Company Have an Identity Crisis? - A company’s brand is perhaps the strongest customer-facing symbol of its value and mission. A strong brand also achieves two more goals: 1) It portr
Digital media reporting: all Greek or all powerful? - A client once told me, “I don’t need to be bothered with digital media reports.”For digital media professionals, this statement stops the music,
